Search clinical trials for: GSK933776

Total 4 results

GlaxoSmithKline

Completed

A Clinical Study to Assess Single and Repeat Doses of a New Medication (GSK933776) in Patients With Alzheimer's Disease

Alzheimer's Disease

Australia, Sweden, Norway
GlaxoSmithKline

Completed

Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease Patient

Alzheimer's Disease

Germany, Sweden
GlaxoSmithKline
Quintiles, Inc.

Completed

Pharmacokinetic (PK) Study of GSK933776 in Healthy Volunteers

Atrophy, Geographic

United States
GlaxoSmithKline

Completed

Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration

Atrophy, Geographic

United States, Canada

3

Subscribe